calcitonin mesotherapy in spinal canal stenosis

Not Applicable

Recruiting

• Conditions: spinal canal stenosis.; Spinal stenosis, lumbar region; M48.06

• Registration Number: IRCT20171201037696N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Pain and other clinical symptoms of lumbar canal stenosis
Complete and sign the consent form
Age between 40 and 75 years

Exclusion Criteria

Diabetes mellitus, rheumatic diseases, collagen and vascular disease, gout. Lupus, nerve damage, neuropathies and brucella
BMI >42
History of trauma and spinal fractures and spondylolisthesis,
History of injections inside or around a joint
bleeding disorders
History of allergy and allergic reaction to used drugs
History of significant liver, kidney and cardiac disorders
Use of anticoagulants

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reducing pain after undergoing mesotherapy. Timepoint: Before starting treatment and 4 and 8 weeks after injection. Method of measurement: Visual Analogue Scale Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Evaluation the effect of calcitonin mesotherapy and epidural steroid on functional improvement. Timepoint: Before starting treatment and 4 and 8 weeks after injection. Method of measurement: Oswestry Disability Index Questionnaire. Quebec Back pain Disability index.